Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ALPHATEC HOLDINGS, INC.

(ATEC)
  Report
Delayed Quote. Delayed Nasdaq - 11/26 01:00:00 pm
10.57 USD   -6.13%
11/17INSIDER SELL : Alphatec Holdings
MT
11/05Needham Adjusts Price Target on Alphatec Holdings to $15 From $18, Maintains Buy Rating
MT
11/04ALPHATEC : Q3 Earnings Snapshot
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/19/2021 11/22/2021 11/23/2021 11/24/2021 11/26/2021 Date
11.27(c) 11.22(c) 11.06(c) 11.26(c) 10.57(c) Last
509 408 571 441 1 377 650 3 757 042 1 348 998 Volume
-0.70% -0.44% -1.43% +1.81% -6.13% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 235 M - -
Net income 2021 -137 M - -
Net Debt 2021 - - -
P/E ratio 2021 -7,54x
Yield 2021 -
Sales 2022 293 M - -
Net income 2022 -100 M - -
Net Debt 2022 - - -
P/E ratio 2022 -11,1x
Yield 2022 -
Capitalization 1 050 M 1 050 M -
Capi. / Sales 2021 4,46x
Capi. / Sales 2022 3,58x
Nbr of Employees 296
Free-Float 62,8%
More Financials
Company
Alphatec Holdings, Inc. is a medical technology company. The Company, through its subsidiary, Alphatec Spine, Inc., and its subsidiaries, designs, develops, manufactures, and markets products for the surgical treatment of spine disorders. The Company offers Organic Innovation Machine, which is focused on developing technology to treat the various pathologies for spine surgery. The CompanyÔÇÖs subsidiaries include... 
More about the company
Ratings of Alphatec Holdings, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about ALPHATEC HOLDINGS, INC.
11/17INSIDER SELL : Alphatec Holdings
MT
11/05Needham Adjusts Price Target on Alphatec Holdings to $15 From $18, Maintains Buy Rating
MT
11/04ALPHATEC : Q3 Earnings Snapshot
AQ
11/042019 Management Objective Strategic Incentive Plan
AQ
11/04ATEC Reports Third Quarter Financial Results and Recent Corporate Highlights - Form 8-K
PU
11/04Earnings Flash (ATEC) ALPHATEC HOLDINGS Posts Q3 Revenue $62.9M, vs. Street Est of $59...
MT
11/04ATEC Reports Third Quarter Financial Results and Recent Corporate Highlights
BU
11/04Alphatec Holdings, Inc Provides Revenue Guidance for the Fiscal Year Ended December 31,..
CI
11/04Alphatec Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months ..
CI
11/01ATEC to Participate in Upcoming Investor Conferences
BU
10/21ALPHATEC : ATEC to Report Third Quarter Financial Results on November 4, 2021
BU
09/29ALPHATEC : ATEC Expands Platform with Launch of InVictus« OsseoScrew« Expandable Spinal Fi..
BU
09/29Alphatec Holdings, Inc. Expands Platform with Launch of InVictus OsseoScrew Expandable ..
CI
09/28ALPHATEC : Forecasts Sequentially Lower Q3 Revenue From Q2; Shares Fall Pre-Bell
MT
09/28ALPHATEC : ATEC Provides Business Update (Form 8-K)
PU
More news
News in other languages on ALPHATEC HOLDINGS, INC.
11/04Earnings Flash (ATEC) ALPHATEC HOLDINGS affiche un chiffre d'affaires de 62,9 millions ..
11/04Alphatec Holdings, Inc. fournit des prévisions de revenus pour l'année fiscale se termi..
09/28Alphatec prévoit un chiffre d'affaires séquentiel plus faible au troisième trimestre pa..
07/02WINFARM : Interview de Patrice Etienne, PDG
06/14EOS IMAGING : ouverture d'une période de remboursement anticipé des Oceanes
More news
Analyst Recommendations on ALPHATEC HOLDINGS, INC.
More recommendations
Chart ALPHATEC HOLDINGS, INC.
Duration : Period :
Alphatec Holdings, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ALPHATEC HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Last Close Price 10,57 $
Average target price 21,17 $
Spread / Average Target 100%
EPS Revisions
Managers and Directors
Patrick S. Miles Chairman, President, CEO & COO
J. Todd Koning Chief Financial Officer & Executive Vice President
Luiz Pimenta Chief Medical Officer
Scott Lish Senior Vice President-Research & Development
Mortimer Berkowitz Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ALPHATEC HOLDINGS, INC.-27.20%1 050
ABBOTT LABORATORIES14.97%222 592
MEDTRONIC PLC-5.20%149 347
BECTON, DICKINSON AND COMPANY-2.05%69 611
HOYA CORPORATION27.96%59 428
DEXCOM, INC.60.11%57 374